ContextVision AB (publ), a software company, engages in the provision of image analysis and imaging for medical systems in Asia, Europe, and America. It offers image quality solutions for ultrasound; and its Rivent platform comprising Rivent, a 2D image enhancement; Rivent Plus, a premium 2D image enhancement product; Rivent 3D, a solution for improving image quality of 3D ultrasound; and Rivent Mobile, a 2D image enhancement for handheld devices for diagnostics in various fields, including radiology, cardiology, women's health, veterinary medicine, and point of-care applications. The company also provides Altumira platform which features scatter correction and improves radiography by enabling radiation dose reduction while enhancing image quality, such as Altumira for static applications; and Altumira Plus for dynamic applications. In addition, it offers image quality solutions for MRI including - GOPView MRI2Plus for the requirements of each application, sequence type, and protocol; implementation projects, software updates, and upgrades and product support services. The company has a strategic clinical development partnership with the University of Washington School of Medicine for collecting medical imaging data to identify a multiparametric biomarker for the screening and staging of the liver disease MASLD. ContextVision AB (publ) was founded in 1983 and is headquartered in Stockholm, Sweden.